IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation
Caitlin M. Tilsed(The University of Western Australia), Hamideh Parhiz(Translational Therapeutics (United States)), Carl H. June(University of Pennsylvania), Nicholas Cerda(University of Pennsylvania), Tyler E. Papp(Translational Therapeutics (United States)), Barbara L. Mui(Arbutus Biopharma (Canada)), Estela Noguera-Ortega(University of Pennsylvania), Barzan A. Sadiq, Ying K. Tam(Arbutus Biopharma (Canada)), Adrian Bot(Unknown), Drew Weissman(California University of Pennsylvania), Haig Aghajanian(Therapeutics Clinical Research), John Scholler(University of Pennsylvania), Steven Μ. Albelda(University of Pennsylvania), Phurin Areesawangkit(Siriraj Hospital), Kenji Kimura(University of Pennsylvania)
Cited by 49
Related Papers
mRNA vaccines — a new era in vaccinology
|Nature Reviews Drug Discovery|2018|4.4k
Rational design of cationic lipids for siRNA delivery
|Nature Biotechnology|2010|1.8k
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
|Nature Nanotechnology|2019|1.6k
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
|Angewandte Chemie International Edition|2012|1.2k
Adhesion molecules and inflammatory injury
|The FASEB Journal|1994|1k